Understanding Immune-Related Adverse Events and Their Management

This chapter explores the incidence and management of immune-related adverse events (irAEs) linked to CTLA-4 and anti-PD therapies. It reviews the prevalence of side effects and provides insights into guidelines from ASCO and NCCN for effectively grading and treating these toxicities.